Osivax appoints Chris Martin to board

Sunday 19 March 2023
Osivax SAS
Appointee name
Chris Martin


Osivax SAS of France has appointed Chris Martin, a serial entrepreneur, to its board of directors to help oversee the company’s vaccine programmes. He is co-founder and board member of ADC Therapeutics SA, a developer of antibody-drug conjugates. He is also chairman of the board of Tokamak Energy Ltd, a fusion energy company.

Osivax announced the appointment on 23 February March 2023.

Copyright 2023 Evernow Publishing Ltd